You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Moderna和默克公佈治療黑色素瘤的癌症疫苗詳細IIb期數據
格隆匯 04-17 15:48
格隆匯4月17日丨默克(MRK.US)和Moderna(MRNA.US)在週日的一次醫療活動中公佈了其癌症疫苗mRNA-4157(V940)聯合KEYTRUDA治療黑色素瘤的IIb期結果。此次IIb期實驗是探究mRNA-4157/V940與keytruda聯用作為完全切除的III/IV期黑色素瘤患者的輔助治療。兩家公司表示,與單獨使用Keytruda相比,這種新型治療方案將復發或死亡的風險降低了44%。皮膚癌、黑色素瘤患者的無復發生存期(RFS)得到了統計學上的顯著改善,並具有臨牀意義。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account